Proton pump inhibitors: actions and reactions.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug Discovery Today

• Publication date

  2009-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.drudis.2009.03.014PMID 19443264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmucosal Gastric Leak Induced by Proton Pump Inhibitors

  2009cited by this paper
• Socio‐demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands

  2009cited by this paper
• Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

  2008cited by this paper
• Omeprazole and refractory hypomagnesaemia

  2008cited by this paper
• [Prevalence of gastro-esophageal reflux disease in patients who attended the emergency room].

  2008cited by this paper
• Gastrointestinal symptoms are still common in a general Western population.

  2008cited by this paper
• The gastric HK-ATPase: structure, function, and inhibition

  2008cited by this paper
• [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole].

  2008cited by this paper
• Severe hypomagnesaemia in long‐term users of proton‐pump inhibitors

  2008cited by this paper
• Pharmacology of proton pump inhibitors

  2008cited by this paper
• Omeprazole Induces Apoptosis in Normal Human Polymorphonuclear Leucocytes

  2008cited by this paper
• Effect of Proton Pump Inhibitor Pantoprazole on Growth and Morphology of Oral Lactobacillus Strains

  2008cited by this paper
• Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.

  2008cited by this paper
• Control of gastric acid secretion in health and disease.

  2008cited by this paper
• Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition

  2008cited by this paper
• Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety

  2008cited by this paper
• Reducing hospital admissions

  2008cited by this paper
• Fundic gland polyp dysplasia is common in familial adenomatous polyposis.

  2008cited by this paper
• Omeprazole Stimulates the Induction of Human Insulin-Like Growth Factor Binding Protein-1 through Aryl Hydrocarbon Receptor Activation

  2008cited by this paper
• Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase

  2008cited by this paper
• Retraction: Blockage of intracellular proton extrusion with proton pump inhibitor induces apoptosis in gastric cancer

  2007cited by this paper
• A review of rabeprazole in the treatment of acid-related diseases

  2007cited by this paper
• Negative Inotropy of the Gastric Proton Pump Inhibitor Pantoprazole in Myocardium From Humans and Rabbits: Evaluation of Mechanisms

  2007cited by this paper
• Stress‐related Mucosal Disease in the Intensive Care Unit: An Update on Prophylaxis

  2007cited by this paper
• Stress-ulcer prophylaxis for general medical patients: a review of the evidence.

  2007cited by this paper
• The Gastric H,K ATPase as a Drug Target: Past, Present, and Future

  2007cited by this paper
• Intravenous proton pump inhibitor use in hospital practice

  2007cited by this paper
• Gastroesophageal reflux disease in pregnancy.

  2007cited by this paper
• The influence of hospitalisation on drug prescription in primary care – a large-scale follow-up study

  2007cited by this paper
• The inhibitory effects of H+K+ATPase inhibitors on human neutrophils in vitro: Restoration by a K+ ionophore

  2007cited by this paper
• Omeprazole-associated Digoxin Toxicity

  2007cited by this paper
• Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.

  2007cited by this paper
• Proton pump inhibitors and the kidney: critical review.

  2007cited by this paper
• Gastrooesophageal reflux disease.

  2007cited by this paper
• Microscopic colitis associated with lansoprazole: Report of two cases and a review of the literature

  2007cited by this paper
• Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease

  2007cited by this paper
• Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

  2007cited by this paper
• Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

  2006cited by this paper
• Review article: the clinical pharmacology of proton pump inhibitors

  2006influential reference
• Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens.

  2006cited by this paper
• Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy

  2006cited by this paper
• Review article: proton pump inhibitors and bacterial overgrowth

  2006cited by this paper
• Gastric H,K-ATPase as a Drug Target

  2006cited by this paper
• Gastroesophageal reflux in infancy and childhood.

  2006cited by this paper
• Long-term proton pump inhibitor therapy and risk of hip fracture.

  2006cited by this paper
• Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH

  2006cited by this paper
• In vitro effects of some drugs on human red blood cell glucose-6-phosphate dehydrogenase enzyme activity

  2006cited by this paper
• Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.

  2006cited by this paper
• Molecular regulation and physiology of the H+,K+ -ATPases in kidney.

  2006cited by this paper
• Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases

  2006cited by this paper
• Loss of acidification of anterior prostate fluids in Atp12a-null mutant mice indicates that nongastric H-K-ATPase functions as proton pump in vivo.

  2006cited by this paper
• Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential.

  2006cited by this paper
• Ion flow regulates left–right asymmetry in sea urchin development

  2006cited by this paper
• Overview of pharmacologic agents for acid suppression in critically ill patients.

  2005cited by this paper
• Proton pump inhibitors: update on their role in acid‐related gastrointestinal diseases

  2005cited by this paper
• Review article: the management of heartburn in pregnancy

  2005cited by this paper
• The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study

  2005cited by this paper
• Pharmacokinetics of Proton Pump Inhibitors in Children

  2005cited by this paper
• Treatment of Gastroesophageal Reflux Disease*

  2005cited by this paper
• Molecular characterization of rat gastric mucosal response to potent acid inhibition.

  2005cited by this paper
• Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro

  2005cited by this paper
• Contemporary strategies for the prevention of stress-related mucosal bleeding.

  2005cited by this paper
• Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists

  2005cited by this paper
• The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes.

  2004cited by this paper
• Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors

  2004cited by this paper
• Omeprazole Induces Apoptosis in Jurkat Cells

  2004cited by this paper
• Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen‐activated protein kinase

  2004cited by this paper
• The evolution of A‐, F‐, and V‐type ATP synthases and ATPases: reversals in function and changes in the H+/ATP coupling ratio

  2004cited by this paper
• Epithelial Barriers, Compartmentation, and Cancer

  2004cited by this paper
• Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.

  2004cited by this paper
• Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

  2004cited by this paper
• Effects of long-term hypergastrinaemia on the ultrastructure of enterochromaffin-like cells in the stomach of the rat, hamster and guinea pig

  2004cited by this paper
• Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.

  2004cited by this paper
• Selective Induction of Apoptosis with Proton Pump Inhibitor in Gastric Cancer Cells

  2004cited by this paper
• Mislocalisation of hephaestin, a multicopper ferroxidase involved in basolateral intestinal iron transport, in the sex linked anaemia mouse

  2004cited by this paper
• Use of Intravenous Proton Pump Inhibitors in Community Practice: An Explanation for the Shortage?

  2004cited by this paper
• Managing Gastro-Oesophageal Reflux Disease in Children

  2004cited by this paper
• Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro

  2003cited by this paper
• GI SNAPSHOT

  2003cited by this paper
• Pharmacogenetics of the Proton Pump Inhibitors: A Systematic Review

  2003cited by this paper
• The Use of Proton Pump Inhibitors in Children

  2003cited by this paper
• Physiology of the Parietal Cell and Therapeutic Implications

  2003cited by this paper
• Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

  2003cited by this paper
• Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions.

  2002cited by this paper
• Regression of fundic gland polyps following acquisition of Helicobacter pylori

  2002cited by this paper
• Factors affecting ammonium uptake by C11 clone of MDCK cells

  2002cited by this paper
• Omeprazole increases permeability across isolated rat gastric mucosa pre‐treated with an acid secretagogue

  2002cited by this paper
• Gastric Polyps and Nodules in Children Receiving Long-Term Omeprazole Therapy

  2002cited by this paper
• Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer

  2001cited by this paper
• Fundic gland polyps are not induced by proton pump inhibitor therapy.

  2001cited by this paper
• Detection and localization of H+-K+-ATPase isoforms in human kidney.

  2001cited by this paper
• Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

  2001cited by this paper
• Occurrence and significance of gastric colonization during acid-inhibitory therapy.

  2001cited by this paper
• Ion Pumps in Polarized Cells: Sorting and Regulation of the Na+,K+- and H+,K+-ATPases*

  2001cited by this paper
• The Functional Role of β Subunits in Oligomeric P-Type ATPases

  2001cited by this paper
• Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats.

  2001cited by this paper
• Proton pump inhibitors: a study of GPs' prescribing.

  2001cited by this paper
• The functional role of beta subunits in oligomeric P-type ATPases.

  2001cited by this paper
• Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

  2001cited by this paper
• The proton-pump inhibitors: similarities and differences.

  2000cited by this paper

• Reprogramming the Catalytic Pocket of Baeyer–Villiger Monooxygenase for Environmentally Compatible Synthesis of a Chiral Sulfoxide Pharmaceutical

  2025cites this paper
• Anti-ulcerogenic potential of lithospermic acid B on NSAID-induced gastric injury in rats

  2025cites this paper
• Proton pump inhibitor leaflets: Is there information on deprescribing?

  2025cites this paper
• Proton Pump Inhibitor Omeprazole Alters the Spiking Characteristics of Proteinoids

  2025cites this paper
• Probiotics reverse gut dysbiosis and memory impairment associated with esomeprazole use in chronically stressed rats: A significant neuroprotective role for cholecystokinin.

  2025cites this paper
• Prescribing practices for proton pump inhibitors among primary care physicians in England: an evaluation

  2024cites this paper
• Enantioselective Binding of Proton Pump Inhibitors to Alpha1-Acid Glycoprotein and Human Serum Albumin—A Chromatographic, Spectroscopic, and In Silico Study

  2024cites this paper
• Biogenic Nanoparticles as Safer Alternatives for Gastric Ulcers: An Update on Green Synthesis Methods, Toxicity, and Their Efficacy in Controlling Inflammation

  2024cites this paper
• New approaches to radio- and chemosensitization using proton pump inhibitors through the lens of tumor cell microenvironment patterns

  2023cites this paper
• Understanding the health risks and emerging concerns associated with the use of long-term proton pump inhibitors

  2023cites this paper
• Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study.

  2023cites this paper
• Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study

  2023cites this paper
• Increased Intestinal Permeability: An Avenue for the Development of Autoimmune Disease?

  2023cites this paper
• Long term use of Proton Pump Inhibitor disrupts intestinal tight junction barrier and exaggerates experimental colitis.

  2022cites this paper
• Facile Synthesis of Benzimidazoles via N-Arylamidoxime Cyclization

  2022cites this paper
• Are Drugs Associated with Microscopic Colitis? A Systematic Review and Meta-Analysis

  2022cites this paper
• Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

  2022cites this paper
• Proton pump inhibitors use and risk of chronic kidney disease and end-stage renal disease: systematic review and meta-analysis.

  2021cites this paper
• Proton pump inhibitors and other pH-buffering agents

  2021cites this paper
• In vitro and in vivo particle coating for oral targeting and drug delivery

  2021cites this paper
• Controversial link between proton pump inhibitors and anticancer agents: review of the literature

  2021cites this paper
• Proton pump inhibitors and peptic ulcer management: Antioxidant mechanisms

  2021cites this paper
• Medication use and microscopic colitis: a multicentre retrospective cohort study

  2021cites this paper
• Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path

  2021cites this paper
• GASTROPROTECTIVE EFFECTS OF VITEX DONIANA LEAF FRACTIONS AGAINST ACETIC ACID INDUCED GASTRIC ULCER MODEL IN ALBINO RATS

  2021cites this paper
• Esomeprazole affects the proliferation, metastasis, apoptosis and chemosensitivity of gastric cancer cells by regulating lncRNA/circRNA-miRNA-mRNA ceRNA networks

  2020cites this paper
• The Acidic Microenvironment: Is It a Phenotype of All Cancers? A Focus on Multiple Myeloma and Some Analogies with Diabetes Mellitus

  2020cites this paper
• The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapy.

  2020cites this paper
• A Review on Vitamin B12 and Iron Deficiency Anaemia Linked with Persistent Use of Gastric Acid Suppressants

  2020cites this paper
• Association of Gastric Acid Suppression and Sorafenib Efficacy in Advanced Hepatocellular Carcinoma

  2020cites this paper
• Acidic Microenvironment Regulates the Severity of Hepatic Ischemia/Reperfusion Injury by Modulating the Generation and Function of Tregs via the PI3K-mTOR Pathway

  2020cites this paper
• Influence of Prolonged Using of Proton Pump Blockers on the Stomach and Colon Microflora in Rats

  2019cites this paper
• The many acid–base manifestations and consequences of hypoxia

  2019cites this paper
• Effects of Diets Containing Seeds of Soybean (Glycine max) on Healing of Acetic Acid Induced Gastric Ulcers in Rats

  2018cites this paper
• ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats

  2018cites this paper
• Proton pump inhibitor use and cancer mortality

  2018cites this paper
• Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography‐tandem Mass Spectrometry, following quality‐by‐design principles for method development

  2018cites this paper
• Embryo–fetal toxicity assessment of vonoprazan in rats and rabbits

  2018cites this paper
• Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects

  2017cites this paper
• Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy

  2017cites this paper
• Proton pump inhibitors use and risk of chronic kidney disease: Evidence-based meta-analysis of observational studies

  2017cites this paper
• Determination and Thermodynamic Modeling of Solid–Liquid Phase Equilibrium for Esomeprazole Sodium in Monosolvents and in the (Ethanol + Ethyl Acetate) Binary Solvent Mixtures

  2017cites this paper
• Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs

  2017cites this paper
• Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.

  2017cites this paper
• Proton Pump Inhibitors and Atrial Fibrillation

  2017cites this paper
• Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering?

  2017cites this paper
• Pharmacokinetic‐Guided Dosing of New Oral Cancer Agents

  2017cites this paper
• Acid-Suppressive Therapy and Risk of Infections: Pros and Cons

  2017cites this paper
• Antiulcerogenic Compounds Isolated from Medicinal Plants

  2016cites this paper
• Hypoxia and Its Acid-Base Consequences: From Mountains to Malignancy.

  2016cites this paper
• Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients.

  2016cites this paper
• High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors

  2016cites this paper
• Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors.

  2016cites this paper
• Microscopic Colitis: What Do We Know About Pathogenesis?

  2016cites this paper
• Hypoxia

  2016cites this paper
• Human Intestinal Barrier Function in Health and Disease

  2016cites this paper
• Safety of proton pump inhibitors

  2016cites this paper
• An Electronic Circular Dichroism Study for the Structure–Chiroptical Relationship of Chiral Proton Pump Inhibitors

  2016cites this paper
• Proton pump inhibitors

  2016cites this paper
• Recent Progress in Preparation of S-Pantoprazole

  2016cites this paper
• Anaphylaxis After the First Dose of Lansoprazole: A Case Report

  2016cites this paper
• Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma.

  2016cites this paper
• PPIs and AF 33

  2015cites this paper
• S-泮托拉唑的研究进展 Recent Progress in Preparation of S-Pantoprazole

  2015cites this paper
• Proton Pump Inhibitors and Atrial Fibrillation

  2015cites this paper
• ReviewProton pump inhibitors as anti vacuolar-ATPases drugs : a novel anticancer strategy

  2015cites this paper
• Evidence-based support for the use of proton pump inhibitors in cancer therapy

  2015cites this paper
• Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

  2015cites this paper
• Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?

  2015influential citation
• Lansoprazole Associated Lymphocytic Colitis With Irritable Bowel Syndrome in a Patient Without Symptoms of Diarrhea

  2015cites this paper
• Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy

  2014cites this paper
• Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors

  2014cites this paper
• Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines

  2014cites this paper
• Ways to improve tumor uptake and penetration of drugs into solid tumors

  2014cites this paper
• The Stereoselectivity of CYP2C19 on R‐ and S‐isomers of Proton Pump Inhibitors

  2014cites this paper
• Uso crônico de inibidores da bomba de prótons na Atenção Primária

  2014cites this paper
• Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.

  2014cites this paper
• Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes

  2013cites this paper
• Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board

  2013cites this paper
• Proton pump inhibitor versus placebo in the short term management of gastro‐esophageal reflux disease

  2013cites this paper
• Gastrointestinal Tract and the Control of Bone Mass

  2013cites this paper
• The role of the gastrointestinal tract in calcium homeostasis and bone remodeling

  2013cites this paper
• The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

  2013cites this paper
• Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?

  2013cites this paper
• Effects of Proton Pump Inhibitor Therapy in the Distal Gut: Putting the Pieces Together

  2012cites this paper
• Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

  2012cites this paper
• Microenvironment and Immunology Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-In fi ltrating T Lymphocytes

  2012cites this paper
• Active Detergent-solubilized H+,K+-ATPase Is a Monomer*

  2012cites this paper
• Distal renal tubular acidosis that became exacerbated by proton pump inhibitor use.

  2012cites this paper
• Is Use of PPIs Related to Increased Intraepithelial Lymphocytes in the Colon?

  2012cites this paper
• Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis

  2012cites this paper
• Teaching the Fundamentals of Biological Research with Primary Literature : Learning from the Discovery of the Gastric Proton Pump

  2012cites this paper
• Áhrif langtímanotkunar prótón-pumpu hemla á gastrín-örvun eftir máltíð

  2012cites this paper
• INIBIDORES DA BOMBA DE PRÓTONS: REVISÃO E ANÁLISE FARMACOECONÔMICA

  2012cites this paper
• Effect of Different Diets on Number and Distribution of Gastrin Cells in the Mucosa of Goats Abomasums

  2012cites this paper
• Is Microscopic Colitis a Drug-induced Disease?

  2012cites this paper
• Pharmacologyonline 2 : 871-878 ( 2011 ) Newsletter Kakkar

  2011cites this paper
• Late entrant over‐the‐counter and Rx market entry strategies: An investigation in the pharmaceutical industry

  2011cites this paper
• Investigation of structure and dissolution properties of a solid dispersion of lansoprazole in polyvinylpyrrolidone

  2011cites this paper
• For Peer Review Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study

  2011cites this paper